Neurodegenerative Disease Research Inc
1 clinical trials · Sponsor
◉ Watch Neurodegenerative Disease Research Inc
| Record | Firm | Date |
|---|---|---|
| Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults (NCT05978908) | Neurodegenerative Disease Research Inc | 2024-02-20 |
Track Neurodegenerative Disease Research Inc automatically
Every clearance here is in the API, with alerts when new ones post.